CYTOREASON
CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human diseases – tissue by tissue, cell by cell. With CytoReason’s massive database and AI-led platform, pharma and biotech companies identify new opportunities, shorten trial phases, reduce development costs and increase the likelihood of approval. To date, six of the world’s top ten pharma companies use CytoReason’s technology.
CYTOREASON
Industry:
Artificial Intelligence Bioinformatics Biopharma Biotechnology Health Care Health Diagnostics Machine Learning Pharmaceutical
Founded:
2016-09-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.cytoreason.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag
Similar Organizations
AccutarBio
AccutarBio employs artificial intelligence to revolutionize drug discovery.
Dxcover
The Future of Cancer Diagnostics
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Scailyte
True precision medicine through single-cell science
Zebra Medical Vision
Zebra Medical Vision is a medical imaging and analytics platform.
Current Advisors List
Current Employees Featured
Founder
Investors List
Asymmetry Ventures
Asymmetry Ventures investment in Series A - CytoReason
OurCrowd
OurCrowd investment in Series A - CytoReason
Newest Events participated
Official Site Inspections
http://www.cytoreason.com Semrush global rank: 3.71 M Semrush visits lastest month: 3.71 K
- Host name: static.18.27.4.46.clients.your-server.de
- IP address: 46.4.27.18
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "CytoReason"
Company - Cytoreason
Ever-growing and ever-updating, CytoReason’s disease models simplify complex molecular mechanisms and illegible disease readouts, making them understandable to researchers of all …See details»
CytoReason - Crunchbase Company Profile & Funding
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. The company …See details»
CytoReason - LinkedIn
CytoReason | 10,058 followers on LinkedIn. The First Cell-Centered Computational Model of Human Disease | CytoReason is a tech company transforming biopharma’s decision-making …See details»
CytoReason: AI disease modelling startup to scale up in US
Jul 18, 2024 Israeli startup CytoReason, which develops computational disease models for predictive insights, has secured $80 million in funding that will scale up its AI disease models …See details»
Invest in CytoReason private stocks | OurCrowd.com
CytoReason’s AI technology integrates big data and deep data to accelerate the expensive, slow, and risky drug development business. The company’s technology is used in a variety of …See details»
CytoReason Company Profile - Office Locations, Competitors
CytoReason is a company that turns human clinical data into biology to deliver data-driven target discovery and drug development. Its platform helps rebuild lost cellular information from gene …See details»
CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and …
Jul 17, 2024 New funding will expand CytoReason’s disease models and proprietary data, enabling R&D leaders at partner companies to make strategic decisions with greater speed …See details»
CytoReason - F6S
CytoReason is a tech company developing a computational model of the human body. The company collects proprietary data from pharma companies and uses it to simulate human …See details»
Home - Cytoreason
CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts. read more. …See details»
Mission, Vision & Core Values of CytoReason
Dec 19, 2024 CytoReason is a pioneering biotech company with a mission to revolutionize the way we understand and utilize biological data. Our vision is to harness the power of cutting …See details»
CytoReason - Contacts, Employees, Board Members, Advisors
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. ... Experience the new Crunchbase, powered by …See details»
CytoReason and the Crohn’s & Colitis Foundation Forge …
May 16, 2024 The Crohn’s & Colitis Foundation is the leading nonprofit organization focused on both research and patient support for inflammatory bowel disease (IBD), with the mission of …See details»
CytoReason and Pfizer sign $110M Deal
TEL AVIV, Israel, September 20, 2022 - CytoReason today announced an extension of its multi-year partnership with Pfizer to use CytoReason’s artificial intelligence technology for Pfizer’s …See details»
The CytoReason Platform
CytoReason’s goal is to create the world’s first platform for computational disease models, and to turn it into the industry standard. We developed our disease models to provide a common …See details»
CytoReason Company Profile, Investors, & Funding - Lucidity …
Jun 9, 2021 CytoReason uses AI to transform biopharma decisions, mapping diseases with extensive data to guide research, compare drugs, and optimize drug portfolios. Total …See details»
CytoReason - Funding, Financials, Valuation & Investors
CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data. New. Resources. ... How much funding has this …See details»
Resources - Cytoreason
CytoReason and the Crohn’s & Colitis Foundation Forge Groundbreaking Data Collaboration to Advance IBD Research. read more. Scientific Publications October 27th, 2023 Reconstructing …See details»
Careers - Cytoreason
We tackle this from day 1 at CytoReason. Our biologists, bioinformaticians, data scientists and engineers sit together in the same room and work on the same projects towards the same …See details»
The Growth Factor - Cytoreason
In return, CytoReason’s collaborative nature fostered greater unity across Pfizer’s own teams, bringing together researchers of all levels in the organization. Though we’ve come a long way …See details»
Technology - Cytoreason
The latest and greatest Created by top immunologists and backed by top-tier publications. Couldn’t be more specific Broken down by disease AND tissue, and even by patient …See details»